PER 0.00% 8.0¢ percheron therapeutics limited

News: ANP Antisense Therapeutics says ATL1102 for MS Phase IIb IND submitted to FDA for review, page-32

  1. 10,996 Posts.
    lightbulb Created with Sketch. 982
    Exactly. Not getting carried away at all. As I'm saying, there is a long way to go and it could be a total flop or spectacular success. All I'm saying that there is a chance of success, where all I've read in the past here has been gloom, doom and total desolation, where the slightest positivity shown by a poster was rudely attacked by a pack of angry piranha. There is room for all points of view, dreams and hopes. At worst it's ok to agree to disagree at times and leave it at that.

    Good fortune all holders
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $72.12M
Open High Low Value Volume
8.1¢ 8.1¢ 7.9¢ $142.6K 1.782M

Buyers (Bids)

No. Vol. Price($)
1 100000 7.9¢
 

Sellers (Offers)

Price($) Vol. No.
8.0¢ 1335 1
View Market Depth
Last trade - 16.10pm 20/08/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.